Boswellia: Dangers, Side Effects and Contraindications

Boswellia (shallaki), the Indian frankincense resin studied for joint comfort, is among the best-tolerated Ayurvedic herbs at usual doses. The adverse effects reported in clinical trials remain broadly mild and rare, mainly digestive. That does not make it trivial in every situation: certain interactions and precautions deserve to be known before starting a course.

Here is what tradition and the available data report — without dramatizing or downplaying.

What are the most common side effects?

• Digestive discomfort: mild nausea, heartburn or loose stools, especially when starting or at high doses. It is the most reported adverse effect in clinical trials.
• Occasional headaches, reported in a minority of cases during trials of concentrated extracts.
• Rare skin reactions with topical application of boswellia essential oil (a separate use from taking it internally).

In the vast majority of cases, these effects remain mild and reversible on stopping or reducing the dose.

Drug interactions to know

Medication	Precaution
Nonsteroidal anti-inflammatory drugs (NSAIDs)	Caution with prolonged combination: potentially cumulative digestive effects.
Blood thinners and antiplatelet drugs	Some data suggest a mild blood-thinning effect; medical advice before combining or before surgery.
Diabetes medications	Potential, modest effect on blood sugar; monitoring if you are on blood-sugar-lowering treatment.

As with any herb taken alongside joint or anti-inflammatory medication, telling your doctor or pharmacist you are taking boswellia remains the basic rule of caution.

Who should abstain or ask first?

• Pregnancy and breastfeeding: insufficient data — avoid as a precaution.
• Sensitive stomach or active ulcer: start at a reduced dose, or avoid altogether during an active flare.
• Scheduled surgery: stop boswellia at least two weeks before, as a precaution tied to a possible effect on clotting.
• Children: no sufficient data for use without pediatric advice.

How do you limit the digestive side effects?

The strategy most cited in practice and in clinical trial protocols is simple: start at half a dose for a week, take boswellia with or just after a meal rather than on an empty stomach, and choose an extract standardized in boswellic acids rather than a poorly dosed raw resin, which is often more irritating. These precautions line up with the general selection criteria detailed in our guide to choosing an Ayurvedic supplement.

Can boswellia replace an anti-inflammatory treatment?

No. The available clinical trials, although broadly favorable on joint comfort, remain modest in size and do not allow it to be considered a substitute for a treatment prescribed for a diagnosed inflammatory condition (rheumatoid arthritis, for example). It can be considered as a complement, never a replacement, and always with your doctor's agreement if a joint condition is under medical care — a point developed in our article on sensitive joints: the Ayurvedic toolkit.

For the general framework of caution applicable to every Ayurvedic herb, see our safety guide.

Side effects in detail

Does boswellia cause side effects? For most adults, Boswellia serrata resin is generally well tolerated: the most common adverse effects, reported in clinical trials on osteoarthritis and inflammatory bowel conditions, are digestive (nausea, heartburn, diarrhea) and generally stay mild. There are, however, real precautions to know: rare allergic skin reactions, a theoretical interaction with anti-inflammatories and anticoagulants, caution before surgery, and pregnancy or breastfeeding to avoid as a precaution.

This article complements our Boswellia (Shallaki): Indian Frankincense for the Joints and boswellia dangers guides by detailing the documented adverse effects and the situations that call for caution. For general safety guidance on Ayurvedic herbs, see our safety and precautions guide.

What are boswellia's digestive side effects?

Digestive upset is among the most commonly reported adverse effects in clinical trials on boswellia, whether for osteoarthritis or chronic inflammatory bowel conditions (Crohn's disease, ulcerative colitis). The most common presentations:

• Mild nausea, especially early in a course or on an empty stomach.
• Heartburn and a feeling of acidity, particularly at high doses.
• Diarrhea or loose stools, generally transient.
• More rarely, bloating or diffuse abdominal discomfort.

A study by Kimmatkar, Thawani, Hingorani and Khiyani, published in 2003 in Phytomedicine, evaluated the efficacy and tolerability of a Boswellia serrata extract in patients with knee osteoarthritis: the extract was generally well tolerated, apart from a few minor gastrointestinal adverse effects, with no notable difference in severity from placebo. A more recent review by Yu, Xiang, Zhang, Zeng, Yang and Li, published in 2020 in BMC Complementary Medicine and Therapies, surveyed several boswellia trials for osteoarthritis and confirms that reported adverse effects mostly stay minor, temporary and reversible, with no serious event attributable to boswellia. Taking boswellia with a meal and starting at a moderate dose limits most of these issues in practice.

Boswellia and the skin: rare allergic reactions

As with any herb, allergic skin reactions remain possible, though reported far less often than digestive issues: rash, redness, itching. They generally appear in the first few days of use, whether taken orally or applied locally (balm, oil). If one appears, the approach is simple: stop use and consult a doctor or pharmacist if symptoms persist or worsen. A history of allergy to other resins or incense should prompt particular caution before trying boswellia for the first time.

Interactions with NSAIDs and anticoagulants: caution is warranted

Boswellia is traditionally used for its anti-inflammatory action, and some of its active molecules (boswellic acids) are studied for their effects on inflammatory processes. This property justifies two theoretical but reasonable precautions:

• Non-steroidal anti-inflammatory drugs (NSAIDs) — ibuprofen, anti-inflammatory-dose aspirin, etc.: an additive effect on inflammation and potentially on the digestive lining is not ruled out. This does not mean a proven dangerous interaction, but combining them without a health professional's guidance is not advised, especially long term.
• Anticoagulants and antiplatelets (warfarin, vitamin K antagonists, low-dose aspirin, etc.): as a precaution, a theoretical additive effect on clotting is raised in the herbal safety literature. Without solid data ruling out any risk, any combination should be cleared by the doctor or pharmacist managing the treatment.

The general rule stays the same as for any herbal supplement: mention boswellia use to your doctor or pharmacist, particularly with long-term anti-inflammatory or anticoagulant treatment.

Planned surgery: why stop boswellia beforehand?

Because of its potential effect on inflammation and, theoretically, on clotting, it is prudent to stop boswellia one to two weeks before scheduled surgery, as with many anti-inflammatory herbs. This avoids any additive risk with treatments or protocols used around the time of the procedure. Always mention boswellia use (and any supplement) to the medical team before an operation, even a minor one.

Pregnancy and breastfeeding: heightened caution

Safety data on boswellia during pregnancy and breastfeeding remain insufficient to guarantee risk-free use: as a precautionary principle, it is therefore recommended to avoid it in both situations. One point worth flagging: tradition sometimes attributes an emmenagogue use to boswellia resin (promoting menstruation), which reinforces the caution to observe during pregnancy. As with most herbs used in Ayurveda, the lack of dedicated trials in pregnant or breastfeeding women justifies abstaining rather than taking an unnecessary risk.

Who should avoid boswellia? The contraindications table

Situation	Recommendation	Why
Pregnancy	Avoid	Insufficient data; traditional emmenagogue use reported for the resin
Breastfeeding	Avoid	Insufficient safety data
NSAID treatment (ibuprofen, anti-inflammatory aspirin...)	Medical advice before combining	Theoretical additive effect on inflammation and the digestive lining
Anticoagulant or antiplatelet treatment	Medical advice essential	Theoretical additive effect on clotting
Planned surgery	Stop 1 to 2 weeks before	Caution linked to anti-inflammatory and clotting effects
History of allergy to resins or incense	Caution, low-dose test	Risk of an allergic skin reaction
Sensitive digestion (ulcer, marked reflux)	Medical advice, take with a meal	Digestive effects (nausea, heartburn, diarrhea) among the most common

As with any herb, extract quality also affects real-world tolerability: a properly dosed product standardized for boswellic acids, detailed in our best boswellia guide, limits bad surprises linked to poorly characterized resins. Finally, boswellia can support joint discomfort, but it never replaces a diagnosis or medical treatment: for persistent or inflammatory joint pain, our joint pain: the Ayurvedic toolkit article clarifies where Ayurveda stops and where seeing a health professional becomes necessary. For the full range of precautions common to Ayurvedic herbs, see our safety and precautions guide.

Pregnancy and breastfeeding: the full picture

Boswellia (Indian frankincense, Boswellia serrata) is not recommended during pregnancy, not because a specific danger has been identified, but because, like the vast majority of herbs featured on this site, it has never been tested in pregnant women in a clinical trial. That distinction matters before reading any further.

A herb otherwise well studied in non-pregnant adults

Boswellia owes its popularity to several randomized clinical trials on knee osteoarthritis. One of the most cited, led by Kimmatkar and colleagues and published in 2003 in Phytomedicine, followed 30 patients with knee osteoarthritis in a placebo-controlled crossover trial: the group receiving boswellia extract reported reduced pain, better knee flexion and increased walking distance, with good tolerability aside from occasional minor digestive upset. This kind of result, obtained in non-pregnant adults with osteoarthritis, explains boswellia's reputation as a "gentle" herb — but it says nothing about how it behaves during pregnancy.

Why a well-tolerated herb is not automatically safe in pregnancy

Pregnancy profoundly changes metabolism, placental blood flow and hormonal sensitivity. A substance well tolerated in a non-pregnant adult could, in theory, behave differently once it crosses the placental barrier, with effects that have simply never been studied, for obvious ethical reasons, in this population. It is this total absence of data, more than any identified danger signal, that justifies the default caution applied to boswellia as to nearly every herb in the Ayurvedic pharmacopeia.

What does ethnobotanical tradition say about boswellia and pregnancy?

Source	What it indicates
Classical Ayurvedic use	Few specific mentions of pregnancy in traditional texts
Modern clinical trials	None conducted in pregnant women
Herbal medicine monographs	Default caution recommended, for lack of data

Unlike herbs such as guggul or saffron, for which a traditional emmenagogue or uterine-stimulant use is specifically documented, boswellia carries no such signal. That does not make it recommended during pregnancy: it simply means the caution applied here reflects a general principle rather than a specifically identified risk.

What to do about joint pain during pregnancy?

Joint and lower-back pain is common during pregnancy, especially in the later stages. Rather than turning to an unevaluated boswellia supplement, validated non-pharmacological approaches remain preferable: proper posture, prenatal physiotherapy, a support belt, moderate local heat, and of course medical advice for pain that is significant or unusual and could have other causes worth ruling out.

What about breastfeeding?

Data on the passage of boswellia's active compounds into breast milk are equally nonexistent. The same default caution applies: avoid boswellia supplements while breastfeeding without explicit medical advice, particularly with a premature or fragile newborn.

Why are so many "gentle" herbs still discouraged by default?

This reasoning can feel frustrating for a herb that has never shown a particular danger signal. Yet it reflects an unavoidable reality of herbal research: running a clinical trial in pregnant women raises considerable ethical questions, which is why almost all available data on herbs comes from non-pregnant adults. Faced with this structural lack of data, expert bodies and reference monographs almost systematically recommend avoiding use as a precaution, rather than presuming a safety that has never been verified. This logic is not unique to boswellia: it applies to the great majority of herbs featured on this site.

Resuming boswellia after childbirth

Outside pregnancy and breastfeeding, boswellia returns to its usual documented use as covered in our articles boswellia review and boswellia dosage. No particular waiting period beyond the end of breastfeeding is generally recommended before resuming a course, aside from the usual advice to seek guidance in case of ongoing treatment or a chronic condition.

Should a one-off dose early in pregnancy be a worry?

A single dose of boswellia taken before knowing one was pregnant, for example for a passing joint pain, should not be a source of retrospective anxiety: no data shows that such an isolated episode causes harm. It remains worth mentioning to a midwife or doctor during pregnancy follow-up, for transparency, without this requiring any particular additional examination absent another risk factor.

Precautions

Boswellia illustrates a common situation on this site: a herb otherwise well documented and generally well tolerated in adults, yet entirely absent from clinical trials conducted during pregnancy. Absence of proof of danger never equals proof of safety. For general guidance, see our guide to Ayurveda and pregnancy and our safety and precautions guide.

Dosage: usual amounts and duration

Boswellia (Boswellia serrata) is almost always used as a standardized extract titrated for boswellic acids, the only form whose dose has been precisely studied in clinical trials on joint comfort, described in boswellia review. The guidelines below are given for information only and do not replace the manufacturer's instructions or professional advice.

Usual doses by boswellic-acid content

Form	Indicative usual dose	Note
Standardized extract (65% boswellic acids)	300 to 500 mg, 2 to 3 times a day	The form most used in clinical trials on the knee
AKBA-enriched extract (3-O-acetyl-11-keto-beta-boswellic acid)	100 to 250 mg per day depending on the product	More concentrated; strictly follow the manufacturer's dose
Traditional resin or powder	Variable, non-standardized dosage	Less consistent; best reserved for uses supervised by a practitioner

What a reference clinical trial shows

A randomized, double-blind, placebo-controlled clinical trial led by Kimmatkar and colleagues, published in 2003 in Phytomedicine, evaluated a standardized Boswellia serrata extract in people with knee joint discomfort. The dose used was 333 mg of standardized extract, three times a day, for 8 weeks, with a significant improvement in pain and mobility compared with placebo. This type of protocol serves as the reference for most current supplements.

What time of day should it be taken?

Boswellia is typically taken with meals, ideally with a little fat: boswellic acids are fat-soluble, and their absorption improves in the presence of lipids. Splitting the daily dose into 2 to 3 intakes, as in the Kimmatkar trial, rather than a single dose, is the most common practice.

How long should a course last?

As detailed in our article boswellia: how long to work, allow 4 to 8 weeks of regular use before judging an effect, the duration used in the available clinical trials. Beyond that, periodic reassessment with a professional helps decide whether to continue or stop the course.

Boswellia and turmeric: should doses be adjusted when combined?

Boswellia is often paired with turmeric, a classic Ayurvedic joint-support duo. In that case, follow the indicative dose for each herb separately rather than combining them at random, and mention this combination to your doctor if you are on anti-inflammatory or anticoagulant treatment.

What to do in case of a mild side effect?

Reported effects are mostly mild and digestive: nausea, stomach discomfort or loose stools, often early in use. Starting at the low end of the indicative dose range, always with a meal, generally limits these issues.

Precautions

Following these dose guidelines does not remove the general precautions, detailed in boswellia: dangers and precautions: pregnancy and breastfeeding to be avoided as a precaution, caution needed with anticoagulant or immunosuppressant treatment or a diagnosed inflammatory disease. A joint that is red, warm and swollen, or sudden sharp pain, calls for prompt medical attention, never a course of herbs. For general guidance, see our safety and precautions guide.